Company Information
- Market
- HKEX Main Board
- Listing Date
- 2015-04-30
- Industry
- Medical Devices
- Fiscal Year End
- Dec 31
- ISIN
- CNE100001W69
- Southbound Connect
- Shanghai · Shenzhen
Industry
45 stocks in this industry
3
>7%
2
5~7%
1
3~5%
12
0~3%
8
0%
13
0~3%
4
3~5%
0
5~7%
2
>7%
Industry RankingsValue (HKD)Rank
Revenue (Last FY)2.87B8/44
Net Profit (Last FY)294.35M10/44
ROE (Last FY)4.63%23/49
Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.
Management
NamePosition
SLShanghai Haohai Biological Technology Co., Ltd.
Executive Director
吴吴剑英
Executive Director
陈陈奕奕
Executive Director
唐唐敏捷
Executive Director
田田敏
Executive Director
游游捷
Non-Executive Director
黄黄明
Non-Executive Director
魏魏长征
Non-Executive Director
陈陈少瑜
Independent Non-Executive Director
沈沈红波
Independent Non-Executive Director
宋宋渊洋
Independent Non-Executive Director
许许多奇
Independent Non-Executive Director
Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-05-29.
About this page
This page shows HAOHAI BIOTEC (06826) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.